Skip to main content
64°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Dexcom Inc
(NQ:
DXCM
)
68.09
+0.56 (+0.83%)
Streaming Delayed Price
Updated: 9:33 AM EDT, Sep 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Dexcom Inc
< Previous
1
2
3
4
5
6
7
Next >
DexCom Stock Gains from GLP-1 Diabetic Users
April 02, 2024
DexCom Inc. (NASDAQ: DXCM) is a leading medical device company in the medical sector that specializes in continuous glucose monitoring (CGM) systems. People
Via
MarketBeat
Stelo by Dexcom First Glucose Biosensor to be Cleared by FDA as Over-the-Counter
March 05, 2024
From
DexCom, Inc.
Via
Business Wire
Dexcom Announces Upcoming Conference Presentation
February 27, 2024
From
DexCom, Inc.
Via
Business Wire
Wall Street is surprisingly most bullish on these 3 Nasdaq stocks
February 14, 2024
Analysts are gradually shifting toward underperforming, less prominent names to find the next big thing - including these three current Wall Street faves
Via
MarketBeat
Dexcom Reports Fourth Quarter and Fiscal Year 2023 Financial Results
February 08, 2024
From
DexCom, Inc.
Via
Business Wire
3 Nasdaq stocks likely to make big earnings splashes
February 07, 2024
Here we look at a few examples of high beta, high standard deviation Nasdaq-100 stocks that are poised to have volatile earnings moves in the near future.
Via
MarketBeat
Topics
Artificial Intelligence
Economy
Exposures
Artificial Intelligence
Interest Rates
Dexcom Schedules Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call for February 8, 2024 at 4:30 p.m. Eastern Time
January 23, 2024
From
DexCom, Inc.
Via
Business Wire
MarketBeat ‘Stock of the Week’: Intuitive Surgical hits new highs
January 22, 2024
With recent obesity drug fears proving to be overblown and equipment placements growing, expect ISRG to reward growth investors with plenty more record highs.
Via
MarketBeat
Topics
Earnings
Exposures
Financial
Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2023 and Initial 2024 Outlook
January 08, 2024
From
DexCom, Inc.
Via
Business Wire
HCA Healthcare Rallies: Weight-loss drugs really a big threat?
January 08, 2024
HCA Healthcare rebounds amid concerns about weight-loss drugs' impact. The healthcare giant's revenue growth hints at resilience despite sector challenges.
Via
MarketBeat
Topics
ETFs
Dexcom to Present at 42nd Annual J.P. Morgan Healthcare Conference
December 19, 2023
From
DexCom, Inc.
Via
Business Wire
Dexcom G7 is Now the Most Accurate, Smallest, Easy-to-Use CGM Connected to the Tandem t:slim X2 Insulin Pump
December 06, 2023
From
DexCom, Inc.
Via
Business Wire
Dexcom Announces Upcoming Conference Presentation
November 21, 2023
From
DexCom, Inc.
Via
Business Wire
Dexcom Unveils Portrait Gallery to Portray Emotional Highs and Lows of Living With Diabetes on World Diabetes Day
November 14, 2023
From
DexCom, Inc.
Via
Business Wire
Dexcom Reports Third Quarter 2023 Financial Results, Raises 2023 Revenue and Margin Guidance, and Announces $500 Million Share Repurchase Program
October 26, 2023
From
DexCom, Inc.
Via
Business Wire
Global Diabetes Care Market Size Expected To Reach $41.71 Billion By 2027
October 25, 2023
EQNX::TICKER_START (OTCPK:CNER),(NYSE:NVO),(NASDAQ:TNDM),(NASDAQ:DXCM),(NASDAQ:LXRX) EQNX::TICKER_END
Via
FinancialNewsMedia
MarketBeat Week in Review – 10/16 - 10/20
October 21, 2023
All the major indexes moved lower on Friday, making it a near certainty that stocks would post their worst week in a month; the bears are firmly in control
Via
MarketBeat
Topics
Bonds
Economy
Exposures
Debt Markets
Economy
Interest Rates
3 Nasdaq-100 Stocks Trading Less Than 10x 2024 Earnings
October 19, 2023
These three Nasdaq-100 stocks can be had for less than 10x 2024 earnings - extra compelling given that Wall Street expects Nasdaq profits will grow next year.
Via
MarketBeat
Topics
Bonds
Economy
Exposures
Debt Markets
Interest Rates
Is the Ozempic-Driven DexCom Selloff Overdone?
October 18, 2023
Has glucose monitor maker DexCom corrected too much on fears of lost sales due to weight loss and diabetes drugs made by Novo Nordisk and Eli Lilly?
Via
MarketBeat
Dexcom Solidifies Global Leadership in Continuous Glucose Monitoring With New Clinical Data Presented at EASD
October 02, 2023
From
DexCom, Inc.
Via
Business Wire
Dexcom Schedules Third Quarter 2023 Earnings Release and Conference Call for October 26, 2023 at 4:30 p.m. Eastern Time.
September 29, 2023
From
DexCom, Inc.
Via
Business Wire
Dexcom U Kicks off 2023 Season With Expanded Roster of Athletes With Diabetes, Building on First-of-its-Kind NIL Program
September 19, 2023
From
Dexcom, Inc.
Via
Business Wire
Why Analysts Say GE's Healthcare Spinoff Has $20 Upside
September 05, 2023
General Electric’s spinoff, GE HealthCare Technologies Inc., is delivering some impressive results and has growth opportunities well worth tuning in to.
Via
MarketBeat
Dexcom Announces Upcoming Conference Presentations
August 30, 2023
From
DexCom, Inc.
Via
Business Wire
Dexcom Appoints Rimma Driscoll to Board of Directors
August 28, 2023
From
DexCom, Inc.
Via
Business Wire
Glucose Monitor Maker DexCom In Buy Zone After Gapping Higher
July 31, 2023
Strong Q2 earnings performance propelled DexCom higher. Investors cheered the glucose monitoring leader's bullish sales view and international expansion plans.
Via
MarketBeat
Dexcom Reports Second Quarter 2023 Financial Results
July 27, 2023
From
DexCom, Inc.
Via
Business Wire
Dexcom Schedules Second Quarter 2023 Earnings Release and Conference Call for July 27, 2023 at 4:30 p.m. Eastern Time
July 06, 2023
From
DexCom, Inc.
Via
Business Wire
Dexcom G7 Receives Health Canada Approval: Next-Generation Continuous Glucose Monitoring System With Unmatched Accuracy Coming to Canadians
July 04, 2023
From
Dexcom, Inc.
Via
Business Wire
Global Continuous Glucose Monitoring Pioneer Dexcom Reveals New Plans to Bring Sensing Technology to Millions More
June 23, 2023
From
Dexcom, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.